Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anne Puel

Showing results (11-20 of 296) with videos related to

Pageof 30
Sort By:
Current Opinion in Immunology|August 29, 2021
Candidiasis in patients with APS-1: low IL-17, high IFN-γ, or both?Quentin Philippot, Jean-Laurent Casanova, Anne Puel
Journal of Human Immunity|January 29, 2026
Human inborn errors of the alternative NF-κB pathwayTom Le Voyer, Jean-Laurent Casanova, Anne Puel
La Revue Du Praticien|March 17, 2016
[Genetic susceptibility to invasive fungal infections]Romain Guery, Fanny Lanternier, Olivier Lortholary, et al.
Current Opinion in Infectious Diseases|September 11, 2024
Inborn errors of immunity and invasive fungal infections: presentation and managementOlivier Paccoud, Adilia Warris, Anne Puel, et al.
Journal of Clinical Immunology|November 5, 2014
Orf Infection in a Patient with Stat1 Gain-of-FunctionSara Sebnem Kilic, Anne Puel, Jean-Laurent Casanova
Journal of Clinical Immunology|June 10, 2017
Human IκBα Gain of Function: a Severe and Syndromic ImmunodeficiencyBertrand Boisson, Anne Puel, Capucine Picard, et al.
Clinical & Translational Immunology|January 17, 2017
Chronic mucocutaneous candidiasis disease associated with inborn errors of IL-17 immunitySatoshi Okada, Anne Puel, Jean-Laurent Casanova, et al.
The Journal of Experimental Medicine|March 23, 2022
Human autoantibodies underlying infectious diseasesAnne Puel, Paul Bastard, Jacinta Bustamante, et al.
European Journal of Immunology|December 21, 2012
Experimental and natural infections in MyD88- and IRAK-4-deficient mice and humansHorst von Bernuth, Capucine Picard, Anne Puel, et al.
Current Opinion in Microbiology|November 13, 2017
Inborn errors of immunity underlying fungal diseases in otherwise healthy individualsJuan Li, Donald C Vinh, Jean-Laurent Casanova, et al.
Pageof 30

Showing results (11-20 of 296) with videos related to

Sort By:
Pageof 30
Current Opinion in Immunology|August 29, 2021
Candidiasis in patients with APS-1: low IL-17, high IFN-γ, or both?Quentin Philippot, Jean-Laurent Casanova, Anne Puel
Journal of Human Immunity|January 29, 2026
Human inborn errors of the alternative NF-κB pathwayTom Le Voyer, Jean-Laurent Casanova, Anne Puel
La Revue Du Praticien|March 17, 2016
[Genetic susceptibility to invasive fungal infections]Romain Guery, Fanny Lanternier, Olivier Lortholary, et al.
Current Opinion in Infectious Diseases|September 11, 2024
Inborn errors of immunity and invasive fungal infections: presentation and managementOlivier Paccoud, Adilia Warris, Anne Puel, et al.
Journal of Clinical Immunology|November 5, 2014
Orf Infection in a Patient with Stat1 Gain-of-FunctionSara Sebnem Kilic, Anne Puel, Jean-Laurent Casanova
Journal of Clinical Immunology|June 10, 2017
Human IκBα Gain of Function: a Severe and Syndromic ImmunodeficiencyBertrand Boisson, Anne Puel, Capucine Picard, et al.
Clinical & Translational Immunology|January 17, 2017
Chronic mucocutaneous candidiasis disease associated with inborn errors of IL-17 immunitySatoshi Okada, Anne Puel, Jean-Laurent Casanova, et al.
The Journal of Experimental Medicine|March 23, 2022
Human autoantibodies underlying infectious diseasesAnne Puel, Paul Bastard, Jacinta Bustamante, et al.
European Journal of Immunology|December 21, 2012
Experimental and natural infections in MyD88- and IRAK-4-deficient mice and humansHorst von Bernuth, Capucine Picard, Anne Puel, et al.
Current Opinion in Microbiology|November 13, 2017
Inborn errors of immunity underlying fungal diseases in otherwise healthy individualsJuan Li, Donald C Vinh, Jean-Laurent Casanova, et al.
Pageof 30